Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL15141778 | 0.97 | ALDH1A1 (0.30) | ALDH1A1MAPK1TDP1 | |
| SCHEMBL828054 | 0.77 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL11905988 | 0.75 | — | — | |
| SCHEMBL7895498 | 0.75 | ALDH1A1 (0.32) | ALDH1A1MAPK1TDP1 | |
| SCHEMBL11905111 | 0.73 | — | — | |
| SCHEMBL828184 | 0.73 | TSHR (0.36) | — | |
| SCHEMBL2345667 | 0.71 | — | — | |
| SCHEMBL7893172 | 0.69 | TDP1 (0.30) | TDP1 | |
| SCHEMBL828392 | 0.69 | TSHR (0.41) | — | |
| SCHEMBL828520 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020107414-A1 | Method of prostaglandin synthesis | ALCON RESEARCH, LTD. | 2002-08-08 | — | — | US | claimed |
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-02-27 | — | — | US | disclosed |
| WO-2023127869-A1 | METHOD FOR PRODUCING N-ALKYL AMINO ACID AND PEPTIDE INCLUDING N-ALKYL AMINO ACID | 中外製薬株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2021130848-A1 | METHOD FOR PRODUCING SILYL ETHERIFIED PRODUCT OF POLYSACCHARIDE | 国立大学法人金沢大学 | 2021-07-01 | — | — | WO | disclosed |
| EP-1950216-B1 | PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND | MITSUI CHEMICALS INC (JP) | 2018-08-29 | — | — | EP | disclosed |
| US-9567354-B2 | Amino acid-modified silane compounds and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-02-14 | — | — | US | disclosed |
| EP-2687529-B1 | CONDENSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL (JP) | 2016-07-13 | — | — | EP | disclosed |
| US-9226921-B2 | Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-01-05 | — | — | US | disclosed |
| US-9029388-B2 | Condensed heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-05-12 | — | — | US | disclosed |
| US-8940758-B2 | Fused heterocyclic compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-01-27 | — | — | US | disclosed |
| US-6291129-B1 | LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-09-18 | — | — | US | disclosed |
| WO-2000059513-A1 | NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1α, 25-DIHYDROXY VITAMIN D¿3? | JOHNS HOPKINS UNIVERSITY (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000035941-A2 | COMBINATORIAL PROCESS FOR PREPARING POLYAMINES | MILLENNIUM PHARMACEUTICALS LIMITED (GB) | 2000-06-22 | — | — | WO | disclosed |
| EP-0927175-A1 | 1-DEOXY BACCATIN III, 1-DEOXY TAXOL AND 1-DEOXY TAXOL ANALOGS AND METHOD FOR THE PREPARATION THEREOF | FLORIDA STATE UNIVERSITY (US) | 1999-07-07 | — | — | EP | disclosed |
| WO-1997042181-A1 | 1-DEOXY BACCATIN III, 1-DEOXY TAXOL AND 1-DEOXY TAXOL ANALOGS AND METHOD FOR THE PREPARATION THEREOF | FLORIDA STATE UNIVERSITY (US) | 1997-11-13 | — | — | WO | disclosed |
| US-4438265-A | Esters of 7-sulfenyliminocephem-4-carboxylic acids | SANKYO COMPANY LIMITED (JP) | 1984-03-20 | — | — | US | disclosed |
| US-4162251-A | Process for the preparation of β-lactam compounds | SANKYO COMPANY LIMITED (JP) | 1979-07-24 | — | — | US | disclosed |
| EP-0000644-A2 | Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-02-07 | — | — | EP | disclosed |
| US-4017488-A | Process for preparing 7β-acylamino-7α-alkoxycephalosporins | SANKYO COMPANY LIMITED (JA) | 1977-04-12 | — | — | US | disclosed |
| US-3960845-A | HALOGENATION | SANKYO COMPANY LIMITED (JA) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | PFAS, EPM2A, CYP2F1 | ALDH1A1 112/4885MAPK1 2709/4885TDP1 2945/4885 |
| US-20020107414-A1 | Method of prostaglandin synthesis | PTGIS, PTGS1, PTGES | ALDH1A1 1474/4885MAPK1 3980/4885TDP1 3272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.